Pancreatic Cancer clinical trials in Hawaii

4 actively recruiting pancreatic cancer trials at 4 sites across Hawaii.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Academic/Other

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial 4-6 months of chemotherapy. Usual care …

Sponsor: NRG Oncology

NCT ID: NCT06958328

Sites in Hawaii:

Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
Queen's Medical Center — Honolulu, Hawaii
Straub Clinic and Hospital — Honolulu, Hawaii
University of Hawaii Cancer Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

Phase 2, Phase 3 Recruiting Industry

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ducta…

Sponsor: Pfizer

NCT ID: NCT06989437

Sites in Hawaii:

Invision, LLC — Honolulu, Hawaii
University of Hawaii Cancer Center — Honolulu, Hawaii
Cardiology Associates, Inc — ‘Aiea, Hawaii

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT04858334

Sites in Hawaii:

Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
Queen's Medical Center — Honolulu, Hawaii
Straub Clinic and Hospital — Honolulu, Hawaii
Queen's Cancer Center - Kuakini — Honolulu, Hawaii

View on ClinicalTrials.gov →

Recruiting Industry

EXoPERT EMERALD Clinical Study

Invitro diagnostic test for multiple cancer diagnosis for patients with early-stage cancers by analyzing surface-enhanced Ramen spectroscopy (SERS) profiles of extracellular vesicles (EV) using artificial intelligence.

Sponsor: EXoPERT

NCT ID: NCT07186296

Sites in Hawaii:

University of Hawaii Cancer Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20